Table of contents:
Latest news & events
Featured presentation
In our own words
IR HOME
News & Events
Press releases
Events
Presentations
Financials
SEC filings
Longitudinal Reporting
Leadership
Executive leadership
Board of directors
Governance documents
Committee composition
Resources
Investor contact
RSS feeds
MENU
Investor Relations
Latest
April 11, 2024
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance
READ MORE
OTC: NVTA
0.00
+
0.00
+
29.63%
Volume:
118,207
20 minute delay
April 18, 2024
IR HOME
News & Events
Press releases
Events
Presentations
Financials
SEC filings
Longitudinal Reporting
Leadership
Executive leadership
Board of directors
Governance documents
Committee composition
Resources
Investor contact
RSS feeds
INVITAE HOME
Latest
April 11, 2024
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance
READ MORE
OTC: NVTA
0.00
+
0.00
+
29.63%
Volume:
118,207
20m delay
April 18, 2024
Latest news & events
Feature presentation
Events
Investor Toolkit
Email Alerts
Sign up to receive Invitae financial information by email.
Email Address:
*
I'D LIKE TO RECEIVE EMAILS ABOUT:
*
Press Release
SEC Filing
Presentation
Event
End of Day Stock Quote
Enter the code shown above.
Investor Contact
1400 16th St.
San Francisco, CA, 94103
Email:
ir@invitae.com
Privacy
|
Terms
|
Licensing
|
Contact
© Invitae Corporation. All rights reserved.
Powered By Q4 Inc.
5.120.1.3